Ondine Biomedical (LON:OBI) Shares Down 2.6% – Here’s What Happened

Shares of Ondine Biomedical Inc. (LON:OBI) fell 2.6% during mid-day trading on Tuesday . The stock traded as low as C$11.00 and last traded at C$11.25. 343,897 shares were traded during trading, an increase of 17% from the average session volume of 295,083 shares. The stock had previously closed at C$11.55.

Ondine Biomedical Trading Down 2.6%

The business has a 50-day moving average of C$13.50 and a 200-day moving average of C$12.86. The stock has a market capitalization of C$5.83 billion, a price-to-earnings ratio of -1.61 and a beta of 0.10. The company has a debt-to-equity ratio of 25.95, a quick ratio of 8.26 and a current ratio of 1.36.

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.